Cargando…

Novel EAAT2 activators improve motor and cognitive impairment in a transgenic model of Huntington’s disease

INTRODUCTION: Glutamate excitotoxicity is causal in striatal neurodegeneration underlying motor dysfunction and cognitive deficits in Huntington’s disease (HD). Excitatory amino acid transporter 2 (EAAT2), the predominant glutamate transporter accounting for >90% of glutamate transport, plays a k...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bhatnagar, Akanksha, Parmar, Visha, Barbieri, Nicholas, Bearoff, Frank, Elefant, Felice, Kortagere, Sandhya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282606/ https://www.ncbi.nlm.nih.gov/pubmed/37351153 http://dx.doi.org/10.3389/fnbeh.2023.1176777

Ejemplares similares

Chromatin and transcriptomic profiling uncover dysregulation of the Tip60 HAT/HDAC2 epigenomic landscape in the neurodegenerative brain
por: Beaver, Mariah, et al.
Publicado: (2021)

Disruption of Tip60 HAT mediated neural histone acetylation homeostasis is an early common event in neurodegenerative diseases
por: Beaver, Mariah, et al.
Publicado: (2020)

Cellular Physiology and Pathophysiology of EAAT Anion Channels
por: Kovermann, Peter, et al.
Publicado: (2022)

Amyloid-β Peptide Impact on Synaptic Function and Neuroepigenetic Gene Control Reveal New Therapeutic Strategies for Alzheimer’s Disease
por: Karisetty, Bhanu Chandra, et al.
Publicado: (2020)

Cellular and Synaptic Localization of EAAT2a in Human Cerebral Cortex
por: Melone, Marcello, et al.
Publicado: (2011)

EAAT5 Glutamate Transporter-Mediated Inhibition in the Vertebrate Retina
por: Lukasiewcz, Peter D., et al.
Publicado: (2021)

Motor–Language Coupling in Huntington’s Disease Families
por: Kargieman, Lucila, et al.
Publicado: (2014)

Progressive Cognitive Deficit, Motor Impairment and Striatal Pathology in a Transgenic Huntington Disease Monkey Model from Infancy to Adulthood
por: Chan, Anthony W. S., et al.
Publicado: (2015)

Altered Grooming Syntax and Amphetamine-Induced Dopamine Release in EAAT3 Overexpressing Mice
por: Escobar, Angélica P., et al.
Publicado: (2021)

EAAT2 as a therapeutic research target in Alzheimer's disease: A systematic review
por: Wood, Oliver W. G., et al.
Publicado: (2022)

Ataxic Symptoms in Huntington’s Disease Transgenic Mouse Model Are Alleviated by Chlorzoxazone
por: Egorova, Polina A., et al.
Publicado: (2020)

Klotho Sensitivity of the Neuronal Excitatory Amino Acid Transporters EAAT3 and EAAT4
por: Almilaji, Ahmad, et al.
Publicado: (2013)

Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities
por: Pirooznia, Sheila K., et al.
Publicado: (2013)

Expression of genes encoding the calcium signalosome in cellular and transgenic models of Huntington's disease
por: Czeredys, Magdalena, et al.
Publicado: (2013)

Impaired K(+) binding to glial glutamate transporter EAAT1 in migraine
por: Kovermann, Peter, et al.
Publicado: (2017)

Glutamate Transporters EAAT4 and EAAT5 Are Expressed in Vestibular Hair Cells and Calyx Endings
por: Dalet, Antoine, et al.
Publicado: (2012)

Longitudinal study revealing motor, cognitive and behavioral decline in a transgenic minipig model of Huntington's disease
por: Baxa, Monika, et al.
Publicado: (2019)

Modified impact of emotion on temporal discrimination in a transgenic rat model of Huntington disease
por: Faure, Alexis, et al.
Publicado: (2013)

The McGill Transgenic Rat Model of Alzheimer's Disease Displays Cognitive and Motor Impairments, Changes in Anxiety and Social Behavior, and Altered Circadian Activity
por: Petrasek, Tomas, et al.
Publicado: (2018)

A novel rhesus macaque model of Huntington’s disease recapitulates key neuropathological changes along with motor and cognitive decline
por: Weiss, Alison R, et al.
Publicado: (2022)

Glutamate transporters, EAAT1 and EAAT2, are potentially important in the pathophysiology and treatment of schizophrenia and affective disorders
por: Parkin, Georgia M, et al.
Publicado: (2018)

Impaired Redox Signaling in Huntington’s Disease: Therapeutic Implications
por: Paul, Bindu D., et al.
Publicado: (2019)

A Computational Study of Astrocytic GABA Release at the Glutamatergic Synapse: EAAT-2 and GAT-3 Coupled Dynamics
por: Flanagan, Bronac, et al.
Publicado: (2021)

Detection of Motor Changes in Huntington's Disease Using Dynamic Causal Modeling
por: Minkova, Lora, et al.
Publicado: (2015)

EAAT2 Expression in the Hippocampus, Subiculum, Entorhinal Cortex and Superior Temporal Gyrus in Alzheimer’s Disease
por: Yeung, Jason H. Y., et al.
Publicado: (2021)

Dysfunction of EAAT3 Aggravates LPS-Induced Post-Operative Cognitive Dysfunction
por: Wang, Xiao-Yan, et al.
Publicado: (2022)

Huntington’s Disease Patient-Derived Astrocytes Display Electrophysiological Impairments and Reduced Neuronal Support
por: Garcia, Veronica J., et al.
Publicado: (2019)

Glutamate Transporters EAAT2 and EAAT5 Differentially Shape Synaptic Transmission from Rod Bipolar Cell Terminals
por: Tang, Fu-Sheng, et al.
Publicado: (2022)

Cognitive-Motor Interference during Walking in Older Adults with Probable Mild Cognitive Impairment
por: Klotzbier, Thomas J., et al.
Publicado: (2017)

Development and Validation of a Nomogram Based on Motoric Cognitive Risk Syndrome for Cognitive Impairment
por: Liu, Yong, et al.
Publicado: (2021)

Impaired Levels of Gangliosides in the Corpus Callosum of Huntington Disease Animal Models
por: Di Pardo, Alba, et al.
Publicado: (2016)

Phosphodiesterase 9A Inhibition Facilitates Corticostriatal Transmission in Wild-Type and Transgenic Rats That Model Huntington’s Disease
por: Chakroborty, Shreaya, et al.
Publicado: (2020)

Mental Rotation as an Indicator of Motor Representation in Patients with Mild Cognitive Impairment
por: Bourrelier, Julien, et al.
Publicado: (2015)

Reversal of Cognitive Impairment in gp120 Transgenic Mice by the Removal of the p75 Neurotrophin Receptor
por: Speidell, Andrew, et al.
Publicado: (2019)

Early Cognitive/Social Deficits and Late Motor Phenotype in Conditional Wild-Type TDP-43 Transgenic Mice
por: Alfieri, Julio A., et al.
Publicado: (2016)

Circadian Abnormalities in Motor Activity in a BAC Transgenic Mouse Model of Huntington’s Disease
por: Oakeshott, Stephen, et al.
Publicado: (2011)

Parkinson’s Disease Progression: Implicit Acquisition, Cognitive and Motor Impairments, and Medication Effects
por: Pavão, Rodrigo, et al.
Publicado: (2012)

Comparison of Sirtuin 3 Levels in ALS and Huntington’s Disease—Differential Effects in Human Tissue Samples vs. Transgenic Mouse Models
por: Buck, Eva, et al.
Publicado: (2017)

Varenicline improves motor and cognitive symptoms in early Huntington’s disease
por: McGregor, Ailsa L, et al.
Publicado: (2016)

Timing and Impact of Psychiatric, Cognitive, and Motor Abnormalities in Huntington Disease
por: McAllister, Branduff, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_eg13ch0v758jq6l5vi4hjh1mii